De Luis, D A <br/><br/>
Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.  [electronic resource] 

 -  European review for medical and pharmacological sciences  Sep 2010 
 - 759-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1128-3602 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Antihypertensive Agents--therapeutic use<br/>Biomarkers--blood<br/>Biphenyl Compounds--therapeutic use<br/>Blood Glucose--metabolism<br/>Blood Pressure--drug effects<br/>Body Mass Index<br/>Body Weight<br/>Cholesterol--blood<br/>Cytokines--blood<br/>Female<br/>Humans<br/>Hypertension--blood<br/>Imidazoles--therapeutic use<br/>Insulin--blood<br/>Irbesartan<br/>Middle Aged<br/>Nicotinamide Phosphoribosyltransferase--blood<br/>Obesity--blood<br/>Prospective Studies<br/>Spain<br/>Tetrazoles--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Triglycerides--blood